Memory loss is an irreversible process of the brain. There is no cure for the symptoms of Alzheimer's disease. However, with adequate support and treatment the memory loss can often be reduced.
This is the first study to demonstrate that loss of memory occurs in both children and aged adults during childhood and adolescence. The data demonstrated that childhood and adolescence are critical periods and that memory loss may be irreversible.
The brain has the ability to perform specialized functions that include consolidation of memories. It also has the ability to recover from damage or damage of part of the brain. In humans, memory loss can affect learning tasks, reading, and the ability to communicate with others. The most frequently noted symptom is forgetfulness in daily life. In older adults, most people do not feel as if their memory is any different than they have had for a few days. Some people's memory may change but only in a short time.\n\nThe brain also has the ability to adapt and change. An individual's abilities change with age, a change in the brain is often observed with normal aging.
In addition to memory exercise and proper nutrition, cognitive skills and mindfulness, can decrease the cognitive symptoms of dementia to some extent. Cognitively stimulating activities and physical exercise are also helpful to maintain a good general state. If these measures fail, the primary strategy is to promote a healthy lifestyle. A healthy lifestyle includes reducing high-fat, high-sugar, and high-salt food and increasing exercise for at least 30 to 45 minutes per session per day. This should be undertaken with the aim of eliminating risks for memory loss. A balanced diet, sufficient sleep, and mental stimulation are a few techniques that can improve memory.
In this nationally representative cohort study of individuals aged 50 and older, episodic memory problems were common. Memory problems are more likely when the cause of memory loss (neurological, vascular/cardiovascular, neurologic, or infectious) is not identified.
Symptoms of memory loss include trouble remembering words, things and personal events. Memory loss can be triggered by diseases such as dementia, alcohol and drug use. Memory changes may also be a symptom of a brain injury. Memory loss that develops suddenly can also suggest signs of dementia.\n
TACS to the hippocampus is safe for this population. TACS has potential to become a treatment modality for the treatment of memory loss. The authors recommend that randomized controlled trials be conducted to establish that tACS can improve memory functioning and improve quality of life for people with dementia and brain aging.
Memory loss is usually multifactorial. The main culprits include traumatic episodes in childhood and aging, among which cognitive status might be a contributory factor (Figure 4).
We conclude that alternating current stimulation (ACS) is more effective than control in improving cognitive deficits after TBI. ACS delivered at the time of tDCS may be a reasonable add-on to cognitive rehabilitation protocols in improving functional outcome and brain plasticity.
Many people with early-stage Alzheimer's disease go on to develop other serious and sometimes debilitating problems, including stroke or cardiovascular disease, with only 25% surviving 2 years after diagnosis. With some patients, the cause of memory loss can be traced over many years. The most common causes of memory loss without associated dementia are strokes, vascular dementia and Alzheimer's disease. The diagnosis of these diseases may be made early on and can lead to treatment that can slow or reverse the memory problems and may prevent the occurrence of severe cognitive impairment.
Currently, no new research and treatment strategies have been found to treat memory loss. With the advancement that neuroscience and the medical community receives, more research is expected to be able to find new ways to treat memory losses. It is key that clinical scientists collaborate with neuroscientists and medical doctors in the future to help the general public and medical communities to better understand memory loss. For more information, visit Power (research).
tACS can modify the amplitude of the tACS-induced modulation of the oscillatory entrainment of the human EEG at the beta frequency (10–20 Hz) on the P3 or the alpha rhythm (7.5–10 Hz).